Found: 39
Select item for more details and to access through your institution.
Innentitelbild: Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation (Angew. Chem. 34/2016).
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 34, p. 9950, doi. 10.1002/ange.201605483
- By:
- Publication type:
- Article
Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation.
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 34, p. 10048, doi. 10.1002/ange.201603488
- By:
- Publication type:
- Article
Targeting of Cancer Cells Using Quantum Dot-Polypeptide Hybrid Assemblies That Function as Molecular Imaging Agents and Carrier Systems.
- Published in:
- Advanced Functional Materials, 2010, v. 20, n. 23, p. 4091, doi. 10.1002/adfm.201000732
- By:
- Publication type:
- Article
Cystine-knot peptides engineered with specificities for α<sub>IIb</sub>β<sub>3</sub> or α<sub>IIb</sub>β<sub>3</sub> and α<sub>v</sub>β<sub>3</sub> integrins are potent inhibitors of platelet aggregation.
- Published in:
- Journal of Molecular Recognition, 2011, v. 24, n. 1, p. 127, doi. 10.1002/jmr.1036
- By:
- Publication type:
- Article
Inside Cover: Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation (Angew. Chem. Int. Ed. 34/2016).
- Published in:
- Angewandte Chemie International Edition, 2016, v. 55, n. 34, p. 9796, doi. 10.1002/anie.201605483
- By:
- Publication type:
- Article
Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation.
- Published in:
- Angewandte Chemie International Edition, 2016, v. 55, n. 34, p. 9894, doi. 10.1002/anie.201603488
- By:
- Publication type:
- Article
Development of Hydrogel-Based Keratoprostheses: A Materials Perspective.
- Published in:
- Biotechnology Progress, 2008, v. 24, n. 3, p. 735, doi. 10.1021/bp070476n
- By:
- Publication type:
- Article
An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01928-2
- By:
- Publication type:
- Article
Measurements of translation initiation from all 64 codons in E. coli.
- Published in:
- Nucleic Acids Research, 2017, v. 45, n. 7, p. 3615, doi. 10.1093/nar/gkx070
- By:
- Publication type:
- Article
Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 2, p. 163, doi. 10.1038/nbt785
- By:
- Publication type:
- Article
Engineering Agatoxin, a Cystine-Knot Peptide from Spider Venom, as a Molecular Probe for In Vivo Tumor Imaging.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060498
- By:
- Publication type:
- Article
Functional Mutation of Multiple Solvent-Exposed Loops in the Ecballium elaterium Trypsin Inhibitor-II Cystine Knot Miniprotein.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0016112
- By:
- Publication type:
- Article
Engineered cystine knot peptides that bind αvβ3, αvβ5, and α5β1 integrins with low-nanomolar affinity.
- Published in:
- Proteins, 2009, v. 77, n. 2, p. 359, doi. 10.1002/prot.22441
- By:
- Publication type:
- Article
Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast.
- Published in:
- Proteins, 2006, v. 62, n. 4, p. 1026, doi. 10.1002/prot.20618
- By:
- Publication type:
- Article
Biocompatibility of poly(ethylene glycol) and poly(acrylic acid) interpenetrating network hydrogel by intrastromal implantation in rabbit cornea.
- Published in:
- Journal of Biomedical Materials Research, Part A, 2015, v. 103, n. 10, p. 3157, doi. 10.1002/jbm.a.35453
- By:
- Publication type:
- Article
Interpenetrating polymer network hydrogel scaffolds for artificial cornea periphery.
- Published in:
- Journal of Materials Science: Materials in Medicine, 2015, v. 26, n. 2, p. 1, doi. 10.1007/s10856-015-5442-2
- By:
- Publication type:
- Article
An engineered ultrahigh affinity bi‐paratopic uPAR targeting agent confers enhanced tumor targeting.
- Published in:
- Biotechnology & Bioengineering, 2024, v. 121, n. 10, p. 3169, doi. 10.1002/bit.28790
- By:
- Publication type:
- Article
A novel protein-engineered hepatocyte growth factor analog released via a shear-thinning injectable hydrogel enhances post-infarction ventricular function.
- Published in:
- Biotechnology & Bioengineering, 2017, v. 114, n. 10, p. 2379, doi. 10.1002/bit.26345
- By:
- Publication type:
- Article
Toward the development of an artificial cornea: Improved stability of interpenetrating polymer networks.
- Published in:
- Journal of Biomedical Materials Research, Part B: Applied Biomaterials, 2011, v. 98B, n. 1, p. 8, doi. 10.1002/jbm.b.31806
- By:
- Publication type:
- Article
An engineered interleukin‐11 decoy cytokine inhibits receptor signaling and proliferation in lung adenocarcinoma.
- Published in:
- Bioengineering & Translational Medicine, 2023, v. 8, n. 6, p. 1, doi. 10.1002/btm2.10573
- By:
- Publication type:
- Article
Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis.
- Published in:
- Bioengineering & Translational Medicine, 2017, v. 2, n. 1, p. 81, doi. 10.1002/btm2.10051
- By:
- Publication type:
- Article
Interrogating and Predicting Tolerated Sequence Diversity in Protein Folds: Application to E. elaterium Trypsin Inhibitor-II Cystine-Knot Miniprotein.
- Published in:
- PLoS Computational Biology, 2009, v. 5, n. 9, p. 1, doi. 10.1371/journal.pcbi.1000499
- By:
- Publication type:
- Article
Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome.
- Published in:
- Science Immunology, 2020, v. 5, n. 54, p. 1, doi. 10.1126/sciimmunol.abe0240
- By:
- Publication type:
- Article
Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.739037
- By:
- Publication type:
- Article
CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.626820
- By:
- Publication type:
- Article
Targeted Contrast-Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-Binding Knottin Peptides.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 3, p. 433, doi. 10.2967/jnumed.109.068007
- By:
- Publication type:
- Article
Evaluation of a <sup>64</sup>Cu-Labeled Cystine-Knot Peptide Based on Agouti-Related Protein for PET of Tumors Expressing α<sub>v</sub>β<sub>3</sub> Integrin.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 2, p. 251, doi. 10.2967/jnumed.109.069831
- By:
- Publication type:
- Article
Diffusion of Protein through the Human Cornea.
- Published in:
- Ophthalmic Research, 2012, v. 48, n. 1, p. 50, doi. 10.1159/000329794
- By:
- Publication type:
- Article
An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-71519-4
- By:
- Publication type:
- Article
Engineered Proteins Pull Double Duty.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 17, p. 1, doi. 10.1126/scitranslmed.3000276
- By:
- Publication type:
- Article
An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis.
- Published in:
- Nature Chemical Biology, 2014, v. 10, n. 11, p. 977, doi. 10.1038/nchembio.1636
- By:
- Publication type:
- Article
An engineered dimeric fragment of hepatocyte growth factor is a potent c‐MET agonist.
- Published in:
- FEBS Letters, 2014, v. 588, n. 24, p. 4831, doi. 10.1016/j.febslet.2014.11.018
- By:
- Publication type:
- Article
Engineered epidermal growth factor mutants with faster binding on-rates correlate with enhanced receptor activation
- Published in:
- FEBS Letters, 2011, v. 585, n. 8, p. 1135, doi. 10.1016/j.febslet.2011.03.044
- By:
- Publication type:
- Article
Dual display of proteins on the yeast cell surface simplifies quantification of binding interactions and enzymatic bioconjugation reactions.
- Published in:
- Biotechnology Journal, 2017, v. 12, n. 5, p. n/a, doi. 10.1002/biot.201600696
- By:
- Publication type:
- Article
Improved mutants from directed evolution are biased to orthologous substitutions.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2006, v. 19, n. 6, p. 245, doi. 10.1093/protein/gzl006
- By:
- Publication type:
- Article
Neutralizing antibodies targeting the SARS‐CoV‐2 receptor binding domain isolated from a naïve human antibody library.
- Published in:
- Protein Science: A Publication of the Protein Society, 2021, v. 30, n. 4, p. 716, doi. 10.1002/pro.4044
- By:
- Publication type:
- Article
<sup>111</sup>In-Labeled Cystine-Knot Peptides Based on the Agouti-Related Protein for Targeting Tumor Angiogenesis.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
<sup>111</sup>In-Labeled Cystine-Knot Peptides Based on the Agouti-Related Protein for Targeting Tumor Angiogenesis.
- Published in:
- Journal of Biomedicine & Biotechnology, 2012, v. 2012, p. 1, doi. 10.1155/2012/368075
- By:
- Publication type:
- Article